Freedom of information: previous disclosures

Martin Bagwell
Telephone: 020 3080 6729
martin.bagwell@mhra.gsi.gov.uk

or

Stephen Wilson
Telephone: 020 3080 6852
stephen.wilson@mhra.gsi.gov.uk 

Previous Freedom of Information requests
Where possible we have tried to make the main subject heading of the replies obvious  eg 'Viagra, Purchase of' so that clicking on the alphabetical button 'v' below should bring up a list of the archived replies referring to that drug. However, where you are unsure exactly what you are looking for, the search facility can used to bring up titles featuring other words in the subject heading  eg searching for 'painkillers' would return a subject title of 'Aspirin and related painkillers'.

A-Z listing
Please note that there are not yet disclosures under every letter on the list below.

•   A copy of the MLX 247 consultation and the responses - Freedom of Information disclosure (12Kb)
•   A copy of the most recent Pharmacovigilance Inspection Report for Novartis Pharmaceuticals - Freedom of Information disclosure (06/426) (15Kb)
•   A copy of the responses to the ARM33, with the annexes - Freedom of Information disclosure (18Kb)
•   A list of approved Human Drug Manufacturing sites by MHRA in India - Freedom of Information disclosure (23Kb)
•   A list of all facilites inspected for GCP compliance since 2004 and details of all findings from these inspections - Freedom of Information disclosure (15Kb)
•   A list of manufacturing sites in India that are registered by the MHRA - Freedom of Information disclosure (15Kb)
•   A list of overseas sites inspected for GMP by the MHRA - Freedom of Information disclosure (14Kb)
•   A list of pharma and biotech companies that the MHRA have conducted GCP inspections at over the past 9 months - Freedom of Information disclosure (14Kb)
•   A list of reclassified medicines - Freedom of Information disclosure (07/019) (20Kb)
•   Abbot Clearstar Pump and Giving Set - Freedom of Information disclosure (19Kb)
•   Aciclovir - Freedom of Information disclosure (13Kb)
•   Adverse reactions in phase 1 trial drugs - Freedom of Information disclosure (28Kb)
•   All inspection reports and responses for the Welsh Blood Service - Freedom of Information disclosure (139Kb)
•   Andrx Pharmaceuticals MHRA inspection from 2-5 October 2006 - Freedom of Information disclosure (14Kb)
•   Any inspection reports for the Rottendorf Pharma GmbH pharmaceutical manufacturing facility in Germany - Freedom of Information disclosure (07/047) (15Kb)
•   Aqua Detox - Freedom of Information disclosure (51Kb)
•   Arms 31 - outcome document - Freedom of Information disclosure (14Kb)
•   Asmanex Twisthaler (PL 00201/0254-5) - Freedom of Information disclosure (4106Kb)
•   Assessment Report on the registration of Atrogel Arnica Gel - Freedom of Information disclosure (14Kb)
•   Atomoxetine - Freedom of Information disclosure (2975Kb)